Supply Issues Proact Medical Ltd Multiple Products Across Various Frameworks (ICN 3330)

• The supply issue with multiple products across various frameworks from Proact Medical is continuing.
• 10 affected product codes remain suspended and unavailable to order:
  • FDA85093, FKK209, FSM1796, FSM1797, FSM3698, FSM3759, FBC85016, FJH85215, FEW85000 and FKK169.
• One product code remains subject to intermittent supply:
  • FSM1769.
• Two of the previously affected product codes are now currently suspended and in the process of being delisted from our online catalogue:
  • FJQ85002 and FWH240.
• 13 product codes are affected in total.
• Potential indirect alternative products are available to order through our online catalogue for most of the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• One product code has no identified alternative products available in our online catalogue:
  • FJH85215 – Blood pressure cuff accessories.
• However, our clinical team have confirmed that if you require an alternative for FJH85215, the following neonatal Philips-compatible blood pressure cuffs are available:
  • FBF1711, FBF1712, FBF1713, FBF1714, FBF1715, FBF1716, FFF658, FJH85162 and FJH85163.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• The supply issue is anticipated to be resolved by 31 August 2026.

Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.

• The supply issue with multiple products across various frameworks from Proact Medical is continuing.
• Ten affected product codes are now suspended and unavailable to order:
  • FDA85093, FKK209, FSM1796, FSM1797, FSM3698, FSM3759, FBC85016, FJH85215, FEW85000 and FKK169.
• Three product codes remain subject to intermittent supply:
  • FJQ85002, FWH240 and FSM1769.
• 13 product codes remain affected in total.
• Potential indirect alternative products are available to order through our online catalogue for most of the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• One code has no identified alternatives in our online catalogue:
  • FJH85215 – Blood pressure cuff accessories.
• However, our Clinical team have confirmed If you require an alternative for FJH85215, please consider one of the following neonatal Philips-compatible blood pressure cuffs:
  • FBF1711, FBF1712, FBF1713, FBF1714, FBF1715, FBF1716, FFF658, FJH85162 and FJH85163.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• The supply issue is now anticipated to be resolved by 31 July 2026.

Change:

• The supplier Proact Medical Ltd has informed us of a supply issue with a number of products over several frameworks.
• There are 13 product codes affected.
• The supply issue is due to shipping delays relating to the ongoing situation in the Middle East.

Impact:          

• All the affected product codes are currently subject to intermittent supply.
• Potential indirect alternative products are available to order through our online catalogue.
• We are currently sourcing further alternatives and updates will be made to the product listing as soon as possible.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• The supply issue is anticipated to be resolved by 29 May 2026. 

Next Steps:               

• Customers are advised to log into our website to view the product listing for further information on the affected product codes and potential alternatives.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.